Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Banco de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Ann Plast Surg ; 60(5): 584-8, 2008 May.
Artículo en Inglés | MEDLINE | ID: mdl-18434836

RESUMEN

Microvascular changes of sludging and stasis are indications of thermal injury in tissue. This study investigates whether microvascular thermal injury can be decreased via topical application of poloxamer-188. Rat mesenteric microvessels were thermally injured and topically suffused with either Ringer's solution (control) or 5% poloxamer-188 in Ringer's solution (experiment). Blood flow was characterized in microvessels as normal or abnormal (ie, sludging and stasis). Topical treatment with poloxamer-188 reduced the percentage of capillaries with abnormal blood flow from 62% to 23%. In venules, this treatment resulted in a decrease from 54% to 34%. These results demonstrated that topically applied poloxamer-188 dramatically reduces the microvascular changes of sludging and stasis because of thermal injury in rat mesenteric microvessels.


Asunto(s)
Quemaduras/tratamiento farmacológico , Mesenterio/efectos de los fármacos , Microcirculación/efectos de los fármacos , Poloxámero/farmacología , Flujo Sanguíneo Regional/efectos de los fármacos , Tensoactivos/farmacología , Administración Tópica , Animales , Modelos Animales de Enfermedad , Hemodinámica , Soluciones Isotónicas/farmacología , Masculino , Mesenterio/irrigación sanguínea , Ratas , Ratas Sprague-Dawley , Solución de Ringer
2.
Ann Plast Surg ; 59(5): 581-90, 2007 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-17992156

RESUMEN

Silicone gel implants have been widely used for breast augmentation and reconstruction since the 1960s. Several alterations to both elastomer shell and filler gel have been made over the years to improve their ability to replicate the natural breast and to decrease the incidence of capsular contracture. The latter is a pathologic process involving the periprosthetic tissues formed in response to the presence of the implant. When severe, capsular contracture may cause firmness, distortion, and pain. In response to many claims of implant-related connective tissue disease, the US Food and Drug Administration placed a moratorium in 1992 on silicone gel breast implants for cosmetic purposes. Despite a preponderance of scientific data to their safety, silicone gel implants are presently available in the United States only as part of limited clinical trials. They continue to be used in Europe and other parts of the world.


Asunto(s)
Implantación de Mama/métodos , Implantes de Mama/efectos adversos , Mamoplastia/métodos , Procedimientos de Cirugía Plástica/métodos , Geles de Silicona/efectos adversos , Siliconas/efectos adversos , Siliconas/química , Enfermedades Autoinmunes/terapia , Mama/patología , Femenino , Humanos , Prótesis e Implantes , Falla de Prótesis , Resultado del Tratamiento
3.
Ann Plast Surg ; 48(2): 148-53, 2002 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-11910219

RESUMEN

Removal of silicone gel from surrounding tissues after implant rupture is difficult. Local inflammation, infection, and silicone granulomas warrant thorough removal of the silicone gel. Shur-Clens (20% solution of the surfactant poloxamer 188), povidone-iodine, and saline are agents that are used to aid in the removal of silicone gel from tissue. The purpose of this study was to compare the efficacy of silicone gel removal by these three agents in vitro. Shur-Clens, povidone-iodine, and saline were compared as solvents for silicone gel. Four weight increments of silicone gel (0.02 g, 0.04 g, 0.06 g, and 0.08 g) were placed on glass slides. These slides were placed in separate beakers containing 40 ml test solution. The slides were soaked for 1 minute with gentle agitation. The slides were removed, rinsed gently with de-ionized water, and placed in a vacuum desiccator to dry. The slides were weighed to determine the amount of silicone removed after soaking in the solution. Analysis of variance was used to determine the significance between the three solvents. The percentages of silicone gel removed for the four weight increments (0.02 g, 0.04 g, 0.06 g, and 0.08 g) in saline were 5.6%, 2.9%, 2.1%, and 5.8%, respectively. In povidone-iodine solution, the percentages were 18.9%, 25.4%, 28.8%, and 51.9%. In Shur-Clens, the percentages were 31.3%, 43.0%, 63.5%, and 79.9%. The greater percentage of silicone gel removed by Shur-Clens was significant compared with the other solutions (p < or = 0.05). Shur-Clens was shown to be a more effective solvent for removal of silicone gel in vitro. This enhanced efficacy is a result of the fact that Shur-Clens contains 20% of the surfactant poloxamer 188. The authors' clinical experience with 7 patients who underwent ruptured silicone breast implant removal demonstrated the superiority of Shur-Clens. Shur-Clens is a surfactant cleanser that is widely available, is inexpensive, and has a good safety profile. They propose the use of Shur-Clens to clean silicone gel spillage to decrease local complications resulting from residual silicone gel.


Asunto(s)
Implantes de Mama/efectos adversos , Poloxámero/uso terapéutico , Geles de Silicona/efectos adversos , Tensoactivos/uso terapéutico , Mama/cirugía , Técnicas In Vitro , Povidona Yodada/uso terapéutico , Falla de Prótesis , Cloruro de Sodio/uso terapéutico , Irrigación Terapéutica
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA